decanoic acid has been researched along with Diabetes Mellitus, Type 2 in 2 studies
decanoate : A fatty acid anion 10:0 that is the conjugate base of decanoic acid.
decanoic acid : A C10, straight-chain saturated fatty acid.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Canagliflozin (CFZ) is a sodium-glucose cotransporter-2 inhibitor (SGLT2) that lowers albuminuria in type-2 diabetic patients, cardiovascular, kidney, and liver disease." | 1.91 | Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, ( Abdelaal, N; Alshawwa, SZ; El-Nabarawi, MA; Elfar, N; Elnawawy, T; Elrefai, MFM; Elzohairy, NA; Fathy Elhabal, S; Gad, RA; Ghaffar, SA; Hamdan, AME; Khalifa, MM; Khasawneh, MA; Mohammed, H; Mohie, PM; Saied, EM; Waggas, DS, 2023) |
| "Low oral bioavailability of berberine due to poor solubility and membrane permeability limits its clinical use for treatment of diabetes." | 1.40 | Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability. ( Hatch, GM; Jingkai, G; Li, C; Ming, Z; Shengnan, W; Xiaojia, B; Zhaojie, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fathy Elhabal, S | 1 |
| El-Nabarawi, MA | 1 |
| Abdelaal, N | 1 |
| Elrefai, MFM | 1 |
| Ghaffar, SA | 1 |
| Khalifa, MM | 1 |
| Mohie, PM | 1 |
| Waggas, DS | 1 |
| Hamdan, AME | 1 |
| Alshawwa, SZ | 1 |
| Saied, EM | 1 |
| Elzohairy, NA | 1 |
| Elnawawy, T | 1 |
| Gad, RA | 1 |
| Elfar, N | 1 |
| Mohammed, H | 1 |
| Khasawneh, MA | 1 |
| Zhaojie, M | 1 |
| Ming, Z | 1 |
| Shengnan, W | 1 |
| Xiaojia, B | 1 |
| Hatch, GM | 1 |
| Jingkai, G | 1 |
| Li, C | 1 |
2 other studies available for decanoic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization,
Topics: Animals; Canagliflozin; Diabetes Mellitus, Type 2; Nanoparticles; Permeability; Povidone; Rabbits; S | 2023 |
Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
Topics: Administration, Oral; Animals; Berberine; Biological Availability; Blood Glucose; Caco-2 Cells; Calo | 2014 |